Comparison of bioavailability and bioequivalence of generic and brand name formulations of escitalopram oxalate tablets in healthy chinese population under fasting …

Q Li, H Huo, W Hu, Y Sui, Y Tang - Drug Design, Development and …, 2020 - Taylor & Francis
… Citation3 Escitalopram is a single S-enantiomer of citalopram… on a 12-month open-label
study of 486 patients treated with … of CYP2C19 poor metabolizers (PMs) within the Chinese

Pharmacogenetic perspectives in improving pharmacokinetic profiles for efficient bioequivalence trials with highly variable drugs: A review

PJ Huang, Y Hsieh, YW Huang, L Ding… - … of Pharmacokinetics, 2021 - Future Science
… [39] had conducted a conventional bioequivalence study in 24 healthy CYP2C19branded
citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study

[HTML][HTML] Establishment and Validation of a Transdermal Drug Delivery System for the Anti-Depressant Drug Citalopram Hydrobromide

Y Sun, Y Ni, R Wang, Z Qin, Z Liu, L Xiao, Y Liu - Molecules, 2024 - mdpi.com
study, the pharmacokinetics of the transdermal CTH delivery system were analyzed in rabbits.
The results showed that the system had good absorptiondosage range (20 mg to 40 mg) […

Estudo de bioequivalência entre duas formulações contendo oxalato de escitalopram

C Sverdloff, CL Guimarães, VM Rezende… - Revista …, 2023 - periodicos.unifesp.br
… An open label, monocentric, randomized, 2x2 crossover study in 36 … determination of
citalopram enantiomers and application to a pharmacokinetic evaluation of generic and reference …

[PDF][PDF] 百乐眠胶囊联合艾司西酞普兰片对失眠伴抑郁焦虑患者睡眠质量, 不良情绪以及神经递质水平的影响

邹瑛, 田道峰, 侯亚婷, 龙星颖, 王慧玲… - 现代生物医学 …, 2021 - biomed.cnjournals.com
branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover
study in healthy Chinese CYP2C19 extensive metabolizers [J]. Clin Drug Investig, 2013, …

[PDF][PDF] 双歧杆菌对母婴分离大鼠成年后肠道敏感性及结肠脑源性神经营养因子表达的影响

孔军伶, 曾令娥, 高妍, 邵长玲… - Progress in Modern …, 2021 - xdswyxjz.cnjournals.com
branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover
study in healthy Chinese CYP2C19 extensive metabolizers [J]. Clin Drug Investig, 2013, …